2023AACE 指南血脂特别治理和动脉粥样硬化预防指南美国临床内分泌协会 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS’ GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF ATHEROSCLEROSIS 〔AACE 指南分为 4 个局部:第 1 局部为绪言,第三世界局部为方法,第 3 局部为执行纲要,第 4 局部为证据根底。本...
表1 胎儿超声心动图检查的潜在适应症 ACE:血管紧张素转换酶;BMI:体重指数。 如胎儿心脏超声筛查结果异常,不论是否存在其他危险因素,都需进行胎儿超声心动图检查; 以下是根据先前发表的指南和当前文件中的先验风险,推荐的胎儿超声心动图适应症。在''ASE 2023''(本文件)的建议中,''不适用''的分类是针对中孕期产科...
cTACE操作过程中,对局限于肝段/亚段的病灶超选择性栓塞时,推荐以肿瘤区碘化油沉积浓密、瘤周出现门静脉小分支显影为栓塞终点(证据等级1,推荐强度A);碘化油乳剂注入后需注入合适粒径的颗粒型栓塞剂进一步栓塞至血流完全停滞;进行选择性较低的...
cTACE 操作过程中,对局限于肝段/亚段的病 灶超选择性栓塞时 ,推荐以肿瘤区碘化油沉积浓密,瘤周出现门静脉小分支显影为栓塞终点(证据 等级 1,推荐强度 A)[57];碘化油乳剂注入后需注入 合适粒径的颗粒型栓塞剂进一步栓塞至血流完全 停滞;进行选择性较低的肝叶水平栓塞时,栓塞终 点是供血动脉呈"干树枝"状,即...
同时,在今年ESC大会上发布的《2023 ESC心肌病管理指南》中HCM药物治疗部分新增了对玛伐凯泰的推荐,指出在合并LVOTO的HCM患者中,心肌肌球蛋白ATP酶抑制剂玛伐凯泰可以在使用超声心动图监测LVEF的指导下,滴定至最大耐受剂量,与β受体阻滞...
1. 对于肝硬化腹水的管理，强烈提倡戒酒和病因治疗（如慢性病毒性肝炎抗病毒治疗）（A1）。2. 腹水患者应避免使用非甾体抗炎药（nonsteroidal anti-infammatory drugs，NSAIDs）、血管紧张素转换酶（angiotensin converting enzyme，ACE）抑制剂、血管紧张素受体阻滞药（angiotensin receptor blockers，ARBs）和其他肾...
[15] Mcclave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) [J]. JPEN J ...
2296-2306. Guidelines for the early management of patients with [14] B R AC A R D S,D U C RO C Q X,M A S J L,e t acute ischemic stroke:a guideline for healthcare al. Mechanical thrombectomy after intravenous professionals from the American Heart Association/ alteplase versus ...
Preterax and Diamicron-MR Controlled EvaluationAHEADAction for HEAlth in DiabetesALLHATAntihypertensive and Lipid-Lowering Treatment to Prevent Heart ATtackALTITUDEALiskiren Trial In Type 2 Diabetes Using Cardio-renal EndpointsANTIPAFANgioTensin II Antagonist In Paroxysmal Atrial FibrillationAPOLLOA Randomized Cont...
“At this point in time, we have no studies with a background of individuals who have experienced disease progression on a contemporary doublet... We want that to change.” —Eric Jonasch, MD The key updates to the NCCN Guidelines in kidney cancer were centered on subsequent therapies, acc...